Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Some neurologists sits at the center of this dementia and brain health question.
The $7 supplement that neurologists are increasingly recommending for high-risk patients is almost certainly vitamin B12. While B12 supplements cost just pennies per day—making a monthly supply available for under $7—it’s not the price that matters. What matters is new research showing that even people with “normal” B12 levels may be experiencing silent neurological damage. A February 2025 study from UC San Francisco revealed a striking finding: individuals with B12 levels in the normal range but on the lower end showed signs of white matter deterioration, neurological damage, and slower cognitive processing—yet they were never advised to supplement.
This article explores why neurologists are now recommending B12 screening and supplementation for older adults and other high-risk populations, what the latest research shows, and how to determine if you or a loved one should consider supplementation. The conventional approach to B12 has long been simple: if your level is within the normal range, you’re fine. Neurologists now argue this threshold-based thinking misses vulnerable patients who are accumulating cognitive decline despite technically normal results. This shift in recommendation isn’t driven by marketing—B12 is dirt cheap. It’s driven by emerging evidence that deficiency is more subtle, more common in aging populations, and more reversible than previously understood.
Table of Contents
- Why Neurologists Are Concerned About B12 Deficiency in Older Adults
- The UC San Francisco Study: Normal Isn’t Enough
- Who Should Be Screened for B12 Deficiency
- How B12 Deficiency Is Tested and Treated
- Common Misconceptions About B12 Status
- Practical Supplementation Options and Costs
- The Broader Shift in Dementia and Cognitive Health Prevention
- Conclusion
Why Neurologists Are Concerned About B12 Deficiency in Older Adults
Vitamin B12 plays a critical role in maintaining myelin—the insulation around nerve fibers—and in producing the neurotransmitters necessary for memory and cognitive function. As people age, particularly those over 75, the body’s ability to absorb B12 from food declines sharply. This isn’t a failure on the part of older adults—it’s a well-documented physiological change. The stomach produces less intrinsic factor, a protein necessary for B12 absorption, making it increasingly difficult to extract B12 from dietary sources like meat, fish, and dairy.
Studies estimate that 10-15% of adults over 65 have true B12 deficiency, but the UC San Francisco research suggests that many more are in a gray zone where levels are “normal” but insufficient for optimal neurological function. The new neurological perspective treats B12 deficiency as a spectrum rather than a binary yes-or-no condition. A patient might have a B12 level of 300 pg/mL—well within the conventional “normal” range of 200-900—yet still experience accelerating cognitive decline due to inadequate neurological B12 levels. This matters because B12 deficiency-related cognitive decline is one of the few reversible causes of cognitive impairment. Unlike some forms of neurodegeneration, B12 supplementation can slow or even partially reverse some cognitive symptoms if caught early enough.

The UC San Francisco Study: Normal Isn’t Enough
In February 2025, UC San Francisco researchers published findings that are reshaping how neurologists approach B12 screening. The study examined patients whose B12 levels fell within the “normal” range but toward the lower end—typically 200-400 pg/mL. Using advanced neuroimaging, researchers found that these patients showed measurable white matter changes and signs of neurological damage comparable to patients with clinically low B12. More concerning, they also demonstrated slower cognitive processing speeds compared to age-matched controls with higher B12 levels. This suggests that the current normal range may be too broad and potentially too lenient for protecting cognitive function.
However, it’s important to recognize a critical limitation: this research doesn’t mean everyone with a B12 level of 400 needs supplementation. The study identified a pattern in people already showing cognitive changes, not a universal threshold. Additionally, the research shows that B12 supplementation benefits people with documented deficiencies or absorption problems most directly. For individuals without absorption issues eating adequate B12-containing foods, routine supplementation hasn’t been shown to prevent decline in healthy people—only to reverse decline in those with actual deficiency. The key distinction neurologists now emphasize is testing, not assumption.
Who Should Be Screened for B12 Deficiency
Adults aged 75 and older represent the highest-risk population for B12 absorption problems. In this age group, studies show approximately 40% have diminished B12 absorption, yet many experience no obvious symptoms. Beyond age, several other populations deserve screening: vegetarians and vegans who don’t eat animal products (the primary dietary source of B12), people taking metformin for diabetes, those with a history of gastrointestinal surgery, and anyone diagnosed with pernicious anemia or other absorption disorders. people with certain autoimmune conditions are also at higher risk, as are those taking long-term proton pump inhibitors or H2 blockers for acid reflux.
Consider the example of Margaret, an 78-year-old whose family noticed she was becoming increasingly forgetful and slower to process conversations. Her general practitioner dismissed her concerns, noting her B12 level was “normal” at 320 pg/mL. However, when her neurologist reviewed her full picture—her age, a history of gastric bypass surgery decades earlier that permanently reduced her absorption capacity, and her measurable cognitive changes—she was recommended B12 supplementation. Within four months of consistent B12 supplementation, Margaret’s family noticed improvements in her alertness and memory. While not all cases show such clear improvement, this pattern is increasingly recognized by specialists.

How B12 Deficiency Is Tested and Treated
Proper B12 assessment involves more than a single blood test. The standard serum B12 level is a starting point, but neurologists increasingly recommend additional markers: methylmalonic acid (MMA) and homocysteine. These metabolic byproducts accumulate when B12 function is compromised, even if serum B12 levels appear normal. If either MMA or homocysteine is elevated alongside a lower-normal B12 level, it suggests functional B12 deficiency at the cellular level. This more comprehensive approach catches subtle deficiencies that a simple serum B12 test might miss.
Supplementation options vary and should match the underlying cause of deficiency. Oral supplementation—typically 500-2000 micrograms daily—works well for dietary deficiency. However, if absorption is the problem (as in pernicious anemia or post-surgical patients), injections of B12 (cyanocobalamin) administered monthly or quarterly bypass the absorption issue entirely and deliver B12 directly into circulation. The advantage of injections is consistency; a monthly injection ensures stable levels without relying on daily oral compliance. The disadvantage is inconvenience compared to taking a tablet. For many high-risk older adults, the injections represent a worthwhile tradeoff because they eliminate the variable of whether someone remembers to take their supplement daily.
Common Misconceptions About B12 Status
Many people assume that if they eat meat and dairy, they’re getting sufficient B12. This misses the absorption component entirely. Someone eating a B12-rich diet can still develop deficiency if their body can’t absorb it effectively. This is why age, surgical history, and medication history matter as much as diet when assessing B12 status. Another widespread misconception is that B12 supplementation provides an energy boost to everyone.
This is marketing language, not neurology. B12 supplementation relieves fatigue and restores mental clarity specifically in people with actual deficiency. In people without deficiency, additional B12 provides no energy benefit, and excess B12 is simply excreted in urine. Additionally, many people are surprised to learn that “normal” B12 levels don’t rule out deficiency-related problems. The normal range is broad, and what’s normal for a young person with high absorption capacity might be insufficient for a 78-year-old with compromised absorption. Neurologists now recommend that high-risk patients—particularly those experiencing cognitive changes—should not be reassured by a “normal” B12 result without understanding where in that normal range they fall and whether they have other markers of functional deficiency like elevated homocysteine.

Practical Supplementation Options and Costs
The affordability of B12 is one reason neurologists can confidently recommend it across populations regardless of socioeconomic status. A month’s supply of oral B12 supplements (500-1000 mcg daily) costs between $5-15 from standard pharmacy retailers, often less in bulk. Prescription B12 injections, typically administered at a doctor’s office, may be covered by Medicare and many insurance plans, making them accessible even for patients on limited incomes. For those without insurance, community health centers often provide B12 injections at reduced or sliding-scale costs.
When choosing a supplement, the form matters. Cyanocobalamin (the form in most supplements and injections) is synthetic but highly effective and stable. Methylcobalamin is marketed as “natural” but isn’t meaningfully superior for most people. High-dose sublingual tablets dissolving under the tongue have become popular, though the evidence that they absorb better than swallowed tablets is limited. For cost-conscious patients, a simple daily oral supplement of 500-1000 mcg is a reasonable starting point, with follow-up testing in 3-4 months to assess whether levels are improving.
The Broader Shift in Dementia and Cognitive Health Prevention
The growing neurologist interest in B12 screening reflects a larger shift in how neurology approaches cognitive decline. Rather than waiting for advanced dementia to develop, there’s increasing emphasis on identifying and treating reversible causes of cognitive impairment early. B12 deficiency is one of the few genuinely reversible contributors to cognitive decline, which explains why neurologists increasingly include it in standard screening protocols for older adults with cognitive complaints. Other reversible causes include thyroid disorders, vitamin D deficiency, and depression, but B12 stands out because both the deficiency and the supplementation are inexpensive and accessible.
Looking ahead, researchers are investigating whether maintaining optimal B12 levels—not just normal levels—might contribute to cognitive reserve and slower aging of the brain. The UC San Francisco study is likely the first of several that will refine our understanding of what B12 levels truly protect the aging brain. As this research matures, we may see a gradual shift in screening recommendations, with neurologists recommending B12 supplementation for more patients based on cognitive risk rather than waiting for documented deficiency. The advantage for patients is clear: a $7 supplement that addresses a modifiable risk factor, supported by growing neurological evidence.
Conclusion
Vitamin B12 represents an increasingly important element of neurological screening for older adults and other high-risk populations. The recent UC San Francisco research showing that even “normal” B12 levels may be insufficient to prevent neurological damage has prompted neurologists to take a closer look at who should be screened and supplemented. For patients over 75, those with absorption problems, vegetarians, and anyone experiencing cognitive changes, a comprehensive B12 assessment—including not just serum B12 but also functional markers like homocysteine and MMA—can identify deficiency-related cognitive decline before it progresses.
If you’re concerned about your B12 status or that of a loved one, the first step is to discuss screening with your primary care physician or neurologist. Be specific: mention cognitive changes, age, dietary restrictions, any surgeries, and current medications. Rather than relying on a single “normal” result, ask for a more detailed assessment including functional markers. At just pennies per day, B12 supplementation is one of the few interventions with both strong scientific support for reversing deficiency-related cognitive decline and genuine accessibility across all income levels.
You Might Also Like
- The Anti Inflammatory Meal Plan That Neurologists Are Recommending for Brain Health
- The Fermented Food That 2 Studies Link to Better Brain Health and Lower Dementia Risk
- The Spice That Reduces Brain Inflammation and May Lower Dementia Risk for $3 a Jar
For more, see Alzheimer’s Association — clinical trials.





